Viral Vector And Plasmid Dna Manufacturing Market Scope And Analysis

  • Report Code : TIPRE00003074
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 140
Buy Now

Viral Vector and Plasmid DNA Manufacturing Market Scope 2031

Buy Now

Viral Vector and Plasmid DNA Manufacturing Market Report Viral Vector and Plasmid DNA Manufacturing Market Size and Share Viral Vector and Plasmid DNA Manufacturing Market Scope and Analysis

Viral Vector and Plasmid DNA Manufacturing Market Report Scope

Report Attribute Details
Market size in 2019 US$ 459.4 Million
Market Size by 2027 US$ 2,247.7 Million
Global CAGR (2019 - 2027) 22.1%
Historical Data 2017-2018
Forecast period 2020-2027
Segments Covered By Product
  • Viral Vectors and Non-viral Vectors
By Application
  • Cancer
  • Inherited Disorders
  • Viral Infections
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Brammer Bio
  • Sanofi
  • FUJIFILM Diosynth Biotechnologies
  • Cell and Gene Therapy Catapult
  • Cobra Biologics
  • FinVector
  • Kaneka Eurogentec S A
  • MassBiologics
  • Spark Therapeutics